Updates On the ASCO 2022 Annual Meeting Updates On the ASCO 2022 Annual Meeting havensmith 2 years ago
Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Ve... Takeda’s Flagship Product Panitumumab (PAN)+mFOLFOX6 Versus bevacizumab (BE... havensmith 2 years ago
Junshi’s domestic Toripalimab’s significant results in... Junshi’s domestic Toripalimab’s significant results in recurrent or metasta... havensmith 2 years ago
Is Paxalisib Better Than Temozolomide In The First-Line... Paxalisib showed positive and promising results in the phase II trial. (Abs... havensmith 2 years ago
With The Emergence of Next-Generation SERDs, Sanofi Mig... With The Emergence of Next-Generation SERDs, Sanofi Might Hit The Mark havensmith 2 years ago